Stenting for Atherosclerotic Renal Artery Stenosis

Carr, Thomas M.; Sabri, Saher S.; Turba, Ulku C.; Park, Auh Whan; Saad, Wael E.A.; Angle, John F.; Matsumoto, Alan H.

doi:10.1053/j.tvir.2010.02.008

Cited by 9 publications

(2 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…D'altronde è stato recentemente evidenziato (18) che l'utilizzo di farmaci inibitori del sistema renina-angiotensina si dimostra ugualmente efficace e privo di effetti collaterali di rilievo anche nei pazienti con stenosi bilaterali e severe delle arterie renali. Carr et al (19) riportano una stabilizzazione o miglioramento della funzione renale e della pressione arteriosa con la rivascolarizzazione, quando correttamente effettuata. Arthurs et al (20) rilevano positivi risultati con la radiologia vascolare interventistica, riscontrando un significativo rallentamento del declino del GFR.…”

Section: Terapiaunclassified

Renal artery stenosis: percutaneous revascularization or medical therapy

Capuano¹,

Coppola²,

Terribile³

et al. 2013

GTND

View full text Add to dashboard Cite

Renal artery stenosis (RAS) is caused by atherosclerosis in 90% of the cases while it is related to fibromuscolar dysplasia in almost 10% of the cases. RAS may cause malignant hypertension and reduction of kidney function. Therefore it is important to carry out an optimal therapy to reduce complications. There is general agreement on the efficacy of a strict medical therapy. On the contrary, the usefulness of a contemporary percutaneous revascularization intervention to ameliorate BP and GFR is questionable. Thus we searched the literature using PubMed by entering the search terms “renal artery stenosis, atherosclerotic renal artery stenosis, renovascular hypertension”. In this review we analyze the epidemiology, physiopathology, diagnosis and, in particular, the different treatment options on the basis of the more recent clinical trials.

show abstract

Section: Terapiaunclassified

Renal artery stenosis: percutaneous revascularization or medical therapy

Capuano¹,

Coppola²,

Terribile³

et al. 2013

GTND

View full text Add to dashboard Cite

show abstract

“…Radiopaque materials, such as synthetic polymers that possess X-ray contrast properties, have attracted significant interest due to their practical utility in the field of biomedical imaging. For example, radiopaque polymers − have been employed in dental plastics, implantable medical devices, for example, stents, catethers, or fiducial markers used to delineate regions of interest within the human body, and nanoscale computed tomography (CT) contrast agents , for noninvasive imaging. Beyond the medical field, radiopaque polymers have also recently been used as photoresists in two-photon lithography, whereby submicron three-dimensional (3D) imaging was achieved using X-ray CT …”

Section: Introductionmentioning

confidence: 99%

Water-Dispersible Bismuth–Organic Materials with Computed Tomography Contrast Properties

Zhang

Naha

Gautam

et al. 2018

ACS Appl. Bio Mater.

View full text Add to dashboard Cite

Two bismuth–organic network polymers were synthesized by means of a one-step polycondensation reaction between an aromatic dithiol/trithiol and triphenylbismuth. The materials were characterized by solid-state UV–vis spectroscopy, Raman spectroscopy, scanning electron microscopy, energy dispersive X-ray spectroscopy, powder X-ray diffraction, elemental microanalysis, and thermogravimetric analysis. Uniform dispersion of the hydrophobic and water-insoluble bismuth-containing polymers in aqueous media was achieved by the addition of 2 kDa poly(ethylene glycol) methyl ether thiol. This enabled quantitative phantom imaging experiments on a clinical computed tomography (CT) scanner, which showed that the coordination polymers possessed strong CT contrast properties. The observed X-ray attenuation properties of each coordination polymer were correlated with its bismuth payload. The X-ray opacity, thermal and chemical stabilities, and aqueous dispersibility of this novel class of bismuth–organic materials make them potentially useful as biomedical CT contrast agents and radiopaque materials.

show abstract

Renal Artery Stenosis

Matsumoto,

Uflacker

2024

IR Playbook

View full text Add to dashboard Cite

Stenting for Atherosclerotic Renal Artery Stenosis

Cited by 9 publications

References 48 publications

Renal artery stenosis: percutaneous revascularization or medical therapy

Renal artery stenosis: percutaneous revascularization or medical therapy

Water-Dispersible Bismuth–Organic Materials with Computed Tomography Contrast Properties

Renal Artery Stenosis

Contact Info

Product

Resources

About